Try our corporate solution for free!
(212) 419-8286

Leading U.S. pharmaceutical products by revenue 2026

Bristol-Myers Squibb's Eliquis and Opdivo are expected to have a place among the top 10 U.S. drugs in 2026, generating some 7.8 billion and 6.1 billion U.S. dollars in revenues, respectively. This statistic displays a projection of the top 10 pharmaceutical products in the United States by revenue in 2026.

Projected top 10 pharmaceutical products by U.S. revenue in 2026

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

July 2020


United States

Survey time period

as of June 2020

Supplementary notes

Values represent company reported sales when available, otherwise based on average of equity analyst estimates.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.